Federated Hermes’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$57.6K Buy
32,742
+29,800
+1,013% +$64.6K ﹤0.01% 1665
2025
Q4
$6.91K Buy
2,942
+308
+12% +$842 ﹤0.01% 1865
2025
Q3
$8.06K Buy
+2,634
New +$7.52K ﹤0.01% 1901

Other funds holding CLOV

Federated Hermes's CLOV Position: Q1 2026 in Review

Federated Hermes increased its Clover Health Investments (CLOV) stake by 1,013% in Q1 2026, buying an estimated $64.6K and bringing the position to 32,742 shares worth $57.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1665.

Federated Hermes first reported a position in CLOV in Q3 2025 and has held it in 3 quarters since. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Federated Hermes held 32,742 shares of Clover Health Investments worth $57.6K as of Q1 2026.
  • Federated Hermes bought 29,800 Clover Health Investments shares in Q1 2026, an estimated $64.6K.
  • Clover Health Investments made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1665 holding.
  • Federated Hermes first reported a position in Clover Health Investments in Q3 2025 and has held it in 3 quarters since.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.